Post-Marketing Study to Assess the Safety & Efficacy of RenalGuard® Therapy for Prevention CSA-AKI

Clinical trial NCT06811805 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06811805
Sponsor: CardioRenal Systems, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

AKI - Acute Kidney Injury Cardiac Surgery Associated - Acute Kidney Injury

Start date: 2025-02-23
Primary completion: 2027-12-31
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.